Cargando…
Preclinical pharmacology and toxicology evaluation of an anti-CD52 monoclonal antibody produced by perfusion fermentation process
Anti-cluster of differentiation 52 (CD52) monoclonal antibody (mAb) has been employed in the treatment of chronic lymphoblastic leukemia and multiple sclerosis. Previously we developed a perfusion process to produce the biosimilar mAb named “Mab-TH.” A series of quality assessments was conducted in...
Autores principales: | Wang, Yanchao, Zheng, Chen, Zhuang, Chao, Fu, Qiang, Qin, Jinyan, Zhang, Baohong, Bian, Yanling, Qi, Nianmin, Zhu, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788881/ https://www.ncbi.nlm.nih.gov/pubmed/34669957 http://dx.doi.org/10.1093/jimb/kuab078 |
Ejemplares similares
-
Diverse mechanisms of bioproduction heterogeneity in fermentation and their control strategies
por: Mu, Xinyue, et al.
Publicado: (2023) -
Reduced viscosity mutants of Trichoderma reesei with
improved industrial fermentation characteristics
por: Bodie, Elizabeth, et al.
Publicado: (2021) -
Genetic evidence for the requirements of antroquinonol biosynthesis by Antrodia camphorata during liquid-state fermentation
por: Xia, Yongjun, et al.
Publicado: (2021) -
The effect of CO(2) concentration on yeast fermentation: rates, metabolic products, and yeast stress indicators
por: Guadalupe-Daqui, Mario, et al.
Publicado: (2023) -
Data-based dynamic compartment model: Modeling of E. coli fed-batch fermentation in a 600 m(3) bubble column
por: Bisgaard, Jonas, et al.
Publicado: (2022)